The Global Myopia And Presbyopia Treatment Market Size Was Valued At USD 16.47 Billion In 2021 And Is Expected To Grow At A Compound Annual Growth Rate (CAGR) Of 8.5% From 2022 To 2030.

Myopia and Presbyopia Treatment Market Overview:

Myopia (myopia) is the most common cause of vision impairment in people under the age of 40, while presbyopia is the normal loss of the ability to focus at close distances that occurs with age. Symptoms of nearsightedness and presbyopia include squinting, eye strain, and headaches. These conditions can be corrected or treated with glasses, contact lenses, or refractive surgery. In addition, eye drops containing drugs are also emerging drugs for the treatment of myopia and presbyopia. Rising geriatric population is one of the major factors driving the market growth as presbyopia is an age-related visual impairment. Vision correction treatment for eye diseases has a remarkable effect, and there is huge room for development. However, the results for presbyopia are not convincing and thus present great potential for development. The increasing prevalence of myopia and presbyopia globally is expected to drive the growth of the myopia and presbyopia treatment market.

Myopia and Presbyopia Treatment market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Myopia and Presbyopia Treatment market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Major Market Segments Covered in Myopia and Presbyopia Treatment Industry Research:

Market Key Players:
Topcon Corporation, Carl Zeiss AG, Bausch & Lomb, Nidek Co., Ltd, Novartis AG, Johnson & Johnson Vision, And Others.

By Type:

• Eyeglasses, Contact Lenses, Intra Ocular Lenses, Other,

By Application:

• Myopia, Presbyopia

By Region:

North America dominated the market with a share of over 20.0% in 2021 and is expected to maintain its leading position during the forecast period owing to the availability of advanced technologies for treating targeted myopia treatment types and the presence of a large number of market players. Asia due to Growing geriatric population, high prevalence of eye-related types of myopia treatment, and rising medical tourism are expected to witness the fastest growth in the Pacific region during the forecast period.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Increasing geriatric population and senior citizens (those above 40 years old) who are prone to vision loss globally are driving the market growth. Most adults in their 40s start to develop age- and lifestyle-related vision myopia Type of treatment. These myopia treatment types are expected to progress to myopia and presbyopia thereby increasing the demand for myopia and presbyopia treatment. Undiagnosed presbyopia is one of the major challenges and is expected to have a significant impact on the vision care industry. The pathophysiology of presbyopia is numerous People remain unclear, leading to delayed diagnosis and increased treatment costs.

People already affected by myopia or presbyopia are turning to telehealth during COVID-19. With widespread adoption of telemedicine, eye care professionals and regular consultants are continuing to monitor myopia progression with minimal impact on market growth. During the COVID-19 pandemic, many medical practices and hospitals have been affected due to some changes in protocols. Due to COVID-19 restrictions, health checks including ophthalmology have been reduced and eye surgery has also been affected by this novel disease outbreak. Many people choose LASIK surgery to correct vision due to the increased risk of spreading infection through contact lenses. This decrease in elective eye surgeries is expected to negatively impact the overall market growth.

Furthermore, the launch of advanced lenses such as intraocular presbyopic lenses and implantable contact lenses is expected to drive the market during the forecast period. Due to their advantages, these lenses are expected to gain sufficient popularity. They have the ability to correct severe myopia, are less prone to dry eye, can be surgically removed, and are ideal for non-LASIK patients.

PresbyLASIK is one of the advanced options available to correct presbyopia. This involves the use of laser therapy to induce spherical aberration, making the cornea multifocal. Another advanced option for people with presbyopia includes corneal inlays. Currently, only two types of corneal inlays are approved for the correction of presbyopia. Increasing number of ongoing studies and broad product lineup are the factors driving the growth of the market.

Myopia and Presbyopia Treatment Market report scope:

Key Takeaways from this Myopia and Presbyopia Treatment Report

• Estimate Myopia and Presbyopia Treatment market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Myopia and Presbyopia Treatment market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Myopia and Presbyopia Treatment market?

The Myopia and Presbyopia Treatment Market is growing at a CAGR of 8.5% During Forecast Period.

 What are the key types of Myopia and Presbyopia Treatment market?

Eyeglasses, Contact Lenses, Intra Ocular Lenses, Other,

What are the key applications of Myopia and Presbyopia Treatment market?

Myopia, Presbyopia                                                                   

Who are the key players in Myopia and Presbyopia Treatment market?

Topcon Corporation, Carl Zeiss AG, Bausch & Lomb, Nidek Co., Ltd, Novartis AG, Johnson & Johnson Vision, And others.